Gene Query: JADE1

Dataset Description Geneva Score
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 212.29
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 77.66
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 74.45
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 73.6
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 63.77
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 63.77
RNA-Seq from early time points in the kidney differentiation protocol 44.69
RNA sequencing analysis of human embryonic stem cells and axial progenitors 41.27
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 40.39
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 40.39
Role of CD133 molecule in WNT response and renal repair 32.9
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 32.62
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 31.48
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 30.15
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 29.51
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 29.43
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 28.69
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 27.74
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 27.63
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 27.48
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 26.93
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 26.72
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 26.46
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 26.18
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 26.02
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 25.75
DIGIT regulates endoderm differentiation of human embryonic stem cells 25.59
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 25.01
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 24.54
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 24.04
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 23.84
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 23.58
Generation of trichogenic adipose-derived stem cells by expression of three factors 23.07
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 22.83
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 22.8
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 21.9
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 21.78
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 21.65
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 21.17
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 20.81
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 20.66
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 20.25
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 19.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 19.37
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 19.36
RNA sequencing of matched nephrectomy samples [RNA-seq] 19.36
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 19.04
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 18.9
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 18.9
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 18.83
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 18.55
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 18.55
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 18.4
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 18.01
Cerebellar differentiation in Ataxia-Telangiectasia 18.0
HNF1 regulates critical functions of the human epididymis epithelium. 17.96
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 17.96
4sUDRB-seq: measuring transcription elongation and initiation genomewide 17.69
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 17.57
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 17.53
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 17.44
Differentially expressed vascular development genes for iPSC-ECs from CDI 17.4
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 17.35
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 17.35
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 17.34
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 17.02
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 16.97
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 16.87
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 16.76
RNA-sequencing in irradiated and normal A549 cells. 16.75
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 16.31
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 16.25
A549 cells and MSR-A549 cells 16.25
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 16.24
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 16.01
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 15.96
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 15.89
Transcriptome analysis in Neobractatin treated cells 15.69
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 15.41
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 15.08
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 15.0
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 14.94
Aortic Valve Tissue: Stenosis vs. Sclerosis 14.87
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 14.78
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 14.78
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 14.65
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 14.54
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 14.51
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 14.5
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 14.28
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 14.27
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 14.25
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 14.25
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 14.21
Targeting MTHFD2 in Acute Myeloid Leukemia 13.8
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 13.61
AMPK signaling for naïve pluripotency 13.38
AMPK signaling for naïve pluripotency [Hs] 13.38
Global gene expression profile of dasatinib-resistant RCH-ACV cells 13.34
Transcriptome analysis of H9 hESC derived cerebral organoids 13.27
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 13.27
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 13.22
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 13.21
13.12
hTERT promotes cell adhesion and migration independent of telomerase activity 13.12
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 13.11
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 13.05
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 13.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 13.0
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 13.0
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 12.97
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 12.9
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 12.86
Expression profiling of etoposide-induced senescent cells 12.74
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 12.72
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 12.72
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 12.7
RNA-seq analysis of BAP1-depleted uveal melanoma cells 12.69
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.66
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 12.61
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 12.56
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 12.51
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 12.51
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 12.49
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 12.49
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 12.45
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.4
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 12.37
In vitro modeling of human germ cell development using pluripotent stem cells 12.37
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.16
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 12.15
Region-specific Innate Antiviral Responses of the Human Epididymis 11.84
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 11.74
IMP3 regulated gene expression in breast cancer cells 11.71
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 11.7
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 11.7
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 11.6
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 11.47
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 11.45
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.38
Total RNA-seq in ALL-SIL upon JQ1 inhibition 11.33
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 11.09
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 11.09
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 11.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 11.06
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 11.06
Ectoderm specification of H1 human embryonic stem cells 11.01
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 10.95
Gene expression analysis of dengue-infected cells 10.88
MEIS1 regulates hematopoiesis in hPSCs 10.66
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 10.66
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.64
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 10.63
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.62
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 10.59
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 10.58
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 10.53
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 10.49
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 10.46
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 10.45
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 10.37
Depicting early human development and germ cell origin with porcine embryos 10.36
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 10.33
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 10.33
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 10.28
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 10.27
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 10.25
RNA-seq analysis of RALD iPSCs after in vitro differentiation 10.24
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 10.14
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 10.12
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 10.07
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 10.07
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 10.03
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 9.95
Regulation of Lipids is Central to Replicative Senescence 9.94
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 9.87
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 9.86
Gene expression profile in breast cancer cells 9.78
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 9.78
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.78
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 9.75
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.74
Examining serotonergic neuron differentiation from human iPSCs 9.74
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.67
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 9.66
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 9.66
Disruption of the exocyst induces podocyte loss and dysfunction 9.56
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 9.48
RNA-seq analysis to identify the genes regulated by p53-SET interplay 9.45
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 9.43
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.41
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.41
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.39
Toxoplasma gondii infection of human retinal pigment epithelial cells 9.36
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.28
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.26
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 9.18
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 9.16
TGF-β promotes genomic instability after loss of RUNX3 9.11
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 9.1
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 9.05
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.05
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.03
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 9.03
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 9.03
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 9.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.02
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 9.02
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 9.02
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 9.0
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 9.0
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.99
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.91
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 8.91
A role for ZNF598 in post-transcriptional gene regulation 8.88
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.88
Primate-specific gene TMEM14B promotes cortical expansion and folding 8.85
The transcriptome of Kawasaki Disease arteritis 8.85
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 8.84
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 8.84
R430: A potent inbibitor of DNA and RNA viruses 8.83
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.82
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 8.81
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.8
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 8.79
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 8.78
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.75
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.75
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 8.71
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 8.69
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.68
mRNA expression profile of Lymphocytes by high-throuput sequencing 8.67
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 8.67
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 8.67
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 8.63
Seletive inhibition of CDK9 in DLBCL cell lines 8.59
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.59
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 8.58
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 8.56
Effect of Influenza virus infection on lncRNA expression in A549 cells 8.55
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 8.5
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.48
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.48
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.42
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.38
Engineering Patient-Specific Tissue Implants 8.35
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 8.34
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.29
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.29
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 8.27
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 8.25
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 8.25
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 8.25
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.19
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 8.17
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 8.14
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 8.14
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 8.13
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 8.1
Effect of drugs on transcriptomic profiles 8.06
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.01
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 8.0
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 7.98
UBC9 knockdown in bladder cancer T24 cell lines 7.97
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 7.97
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 7.97
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.96
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.95
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 7.92
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.87
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.86
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.86
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.85
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.76
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.7
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.7
Ribosomal footprinting of MDA-Parental and MDA-LM2 7.7
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 7.68
High-Throughput Kinetic Analysis of Fractional Killing 7.68
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 7.67
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 7.67
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 7.67
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 7.63
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 7.6
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 7.6
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 7.56
RNA-seq of naive and primed ES cells 7.53
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 7.52
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 7.5
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 7.47
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 7.46
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 7.46
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 7.43
Differential gene expression in Jagged1 treated human dental pulp cells. 7.38
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 7.34
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.34
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.33
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 7.27
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 7.25
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 7.25
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 7.25
High-efficiency RNA-based reprogramming of human primary fibroblasts 7.24
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 7.21
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.19
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.19
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 7.16
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 7.06
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.95
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.91
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.88
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.87
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 6.84
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 6.82
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 6.74
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.69
Derivation and differentiation of haploid human embryonic stem cells 6.68
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.59
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.56
HNRNPM-regulated splicing dependencies in prostate cancer 6.47
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 6.47
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.36
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.36
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 6.34
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.31
Epigenome regulation during epidermal lineage commitment [RNA-seq] 6.27
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 6.25
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 6.25
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 6.24
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.19
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 6.15
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.15
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 6.14
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.11
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.02
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.98
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.97
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.97
Gene expressions of H9s in different culture systems 5.97
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.96
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.96
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.79
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 5.74
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 5.72
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 5.7
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 5.6
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.6
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 5.58
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.5
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 5.47
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 5.44
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.39
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.28
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 5.24
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 5.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 5.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 5.24
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.08
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.94
ARID1A regulates condensin II distribution and chromosomal partition 4.94
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 4.87
STX4 Over-Expression in Human islets 4.77
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 4.73
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 4.72
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 4.72
scRNASeq analysis of cycling cardiomyocytes 4.71
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 4.71
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 4.71
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 4.7
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 4.69
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 4.67
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.64
Molecular Criteria for Defining the Naive Human Pluripotent State 4.58
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.58
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 4.56
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.55
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 4.54
FGF2 regulation of gene expression in stable inducible Neurons 4.54
Postnatal lipids drive hepatocyte maturation 4.49
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.47
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.47
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 4.45
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.26
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.22
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 4.13
A549 cell transcriptome responses to infection with H7N9 influenza virus 4.12
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.0
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 3.98
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.98
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.96
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 3.94
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 3.93
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 3.91
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.9
Capturing the Interactome of Newly Transcribed RNA 3.9
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.89
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.85
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.85
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.84
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 3.8
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 3.8
RNA-seq analysis of differentiating human erythroblasts 3.76
UV_24h_GRO-Seq 3.72
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 3.69
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.68
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.62
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.62
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.61
Microglia innatly develop within cerebral organoids 3.57
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.56
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.44
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.44
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 3.29
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.25
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 3.25
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.2
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.19
hESC neural differentiation 3.18
RNA-seq analysis of gene expression patterns during hESC neural differentiation 3.18
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.18
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.15
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.06
Loss of CREBBP results in gene expression repression in lymphoma cells 3.06
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.73
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.73
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.69
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.67
Functional significance of the HIV-1 Tat signature amino acid residues 2.64
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 2.44
Exploring ILF2 regulatory genes by next-generation sequencing 2.41
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.39
Effect of from Human Umbilical Vein Endothelial Cells 2.33
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.32
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.32
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 2.31
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.31
Transcriptome of diurnal human blood neutrophils 2.29
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 2.15
Dynamic reorganization of nuclear architecture during human cardiogenesis 2.07
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 2.07
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.0
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.99
Molecular analysis of renal cell carcinoma with unclassfied histology 1.99
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.98
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.95
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 1.89
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.86
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.86
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.78
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.78
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.7
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 1.68
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.58
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.54
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.5
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.5
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.48
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.38
Myc activation coordinates gene transcription and protein translation responses 1.29
RNA-seq analysis upon ARID1B overexpression 1.18
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.1
4sU-seq of HFF exposed to salt and heat stress 1.06
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.06
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.99
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.97
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.97
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.95
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.93
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.88
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.86
BMS-470539 on human synovial fibroblasts 0.85
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.82
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.81
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.72
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.7
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.65
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.65
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.65
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.65
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.57
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.54
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.53
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.48
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.48
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.48
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.48
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.42
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.29
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.25
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.25
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.16
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.15
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.14
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.14
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.13
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.13
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.06
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.04
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.01
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation